13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001823138
Total reported value
$8.7B
$8.7B
29 檔
7.8%
In Q4 2024, Two Seas Capital LP's U.S. equity holdings reached a combined market value of $8.7B, distributed across 29 disclosed stock positions.
In Q4 2024, Two Seas Capital LP displayed an active expansion posture, initiating 8 new positions and adding to 14 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TLN | Talen Energy CORP | Stock-Utilities | 15.99% | -1.39% | +104.51% | |
| 2 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 13.38% | — | -4.39% | |
| 3 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 10.39% | -2.95% | +4.55% | |
| 4 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 10.13% | -25.42% | — | |
| 5 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 8.79% | +45.96% | NEW | |
| 6 | CORZ | Core Scientific Inc | Stock-Tech | 7.57% | -5.01% | +9.24% | |
| 7 | VST | Vistra CORP | Stock-Utilities | 4.52% | -0.75% | +50.03% | |
| 8 | CLMT | Calumet Inc | Stock-Other | 4.15% | -1.53% | +604.29% | |
| 9 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 3.90% | — | +90.63% | |
| 10 | SHC | Sotera Health Co | Stock-Other | 3.42% | -0.75% | +624.03% | |
| 11 | IMVT | Immunovant Inc | Stock-Other | 3.24% | -0.60% | +123.41% | |
| 12 | ABUS | Arbutus Biopharma CORP | Stock-Other | 2.47% | -1.37% | +4.22% | |
| 13 | CEG | Constellation Energy | Stock-Utilities | 1.90% | — | +293.85% | |
| 14 | TDAY | USA Today Co Inc | Stock-Other | 1.32% | -1.33% | — | |
| 15 | ESPR | Esperion Therapeutics Inc | Stock-Other | 1.18% | — | -5.37% | |
| 16 | META | Meta Platforms Inc-class A | Stock-Comm Services | 0.94% | — | -48.51% | |
| 17 | HUT | Hut 8 CORP | Stock-Financials | 0.84% | -0.01% | +132.68% | |
| 18 | ARDX | Ardelyx Inc | Stock-Other | 0.81% | — | — | |
| 19 | ✓ | Bitdeer Technologies Group | Stock-Other | 0.81% | -1.07% | EXIT | |
| 20 | IREN | IREN Limited | Stock-Other | 0.73% | -0.09% | +212.73% | |
| 21 | ADAPY | Adaptimmune Therapeutics-adr | Stock-Other | 0.69% | — | — | |
| 22 | SONO | Sonos Inc | Stock-Other | 0.69% | -0.19% | EXIT | |
| 23 | ESPR 4 11-15-25Bond | Esperion Therapeutics | Bond | 0.45% | — | — | |
| 24 | APLD | Applied Digital CORP | Stock-Tech | 0.44% | +0.01% | NEW | |
| 25 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 0.41% | — | -37.50% | |
| 26 | SOC | Sable Offshore CORP | Stock-Other | 0.31% | +0.24% | — | |
| 27 | CORZW | Core Scientific Inc - 27 | Stock-Other | 0.20% | -0.08% | — | |
| 28 | ✓ | Bit Digital Inc | Stock-Other | 0.17% | — | +60.62% | |
| 29 | OMEX | Odyssey Marine Exploration | Stock-Other | 0.16% | -0.05% | +2449.05% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | +10.1% | NEW | New buy |
| 2 | QQQ | Invesco Qqq Trust Series 1 | +8.8% | NEW | New buy |
| 3 | CLMT | Calumet Inc | +3.3% | +604.29% | Add |
| 4 | TLN | Talen Energy CORP | +3% | +104.51% | Add |
| 5 | SHC | Sotera Health Co | +2.3% | +624.03% | Add |
| 6 | TDAY | USA Today Co Inc | +1.3% | NEW | New buy |
| 7 | CEG | Constellation Energy | +0.9% | +293.85% | Add |
| 8 | ARDX | Ardelyx Inc | +0.8% | NEW | New buy |
| 9 | ✓ | Bitdeer Technologies Group | +0.8% | NEW | New buy |
| 10 | ADAPY | Adaptimmune Therapeutics-adr | +0.7% | NEW | New buy |
| 11 | APLD | Applied Digital CORP | +0.4% | NEW | New buy |
| 12 | HUT | Hut 8 CORP | +0.4% | +132.68% | Add |
| 13 | IREN | IREN Limited | +0.4% | +212.73% | Add |
| 14 | SOC | Sable Offshore CORP | +0.3% | NEW | New buy |
| 15 | OMEX | Odyssey Marine Exploration | +0.2% | +2449.05% | Add |
| 16 | IMVT | Immunovant Inc | +0.1% | +123.41% | Add |
| 17 | ✓ | Bit Digital Inc | -0.1% | +60.62% | Add |
| 18 | CORZW | Core Scientific Inc - 27 | -0.1% | — | Unchanged |
| 19 | VST | Vistra CORP | -0.3% | +50.03% | Add |
| 20 | WULF | Terawulf Inc | -0.3% | EXIT | Sold out |
| 21 | SONO | Sonos Inc | -0.4% | — | Unchanged |
| 22 | ESPR 4 11-15-25Bond | Esperion Therapeutics | -0.4% | — | Unchanged |
| 23 | PCRX | Pacira Biosciences Inc | -0.4% | EXIT | Sold out |
| 24 | ARQT | Arcutis Biotherapeutics Inc | -0.5% | EXIT | Sold out |
| 25 | ESPR | Esperion Therapeutics Inc | -0.6% | -5.37% | Trim |
| 26 | GOOGL | Alphabet Inc-cl A | -0.7% | -37.50% | Trim |
| 27 | ✓ | Avadel Pharmaceuticals PLC ADR | -0.9% | +90.63% | Add |
| 28 | META | Meta Platforms Inc-class A | -2.4% | -48.51% | Trim |
| 29 | ABUS | Arbutus Biopharma CORP | -2.8% | +4.22% | Add |
| 30 | CORZ | Core Scientific Inc | -3.4% | +9.24% | Add |
| 31 | EXEL | Exelixis Inc | -5.7% | EXIT | Sold out |
| 32 | INDV | Indivior Pharmaceuticals, Inc. | -7.2% | -4.39% | Trim |
| 33 | ROIV | Roivant Sciences Ltd. | -7.8% | +4.55% | Add |
According to official SEC Form 13F filings, Two Seas Capital LP reported a total U.S. public equity portfolio value of $8.7B across 29 disclosed positions in Q4 2024.
During Q4 2024, Two Seas Capital LP's top holdings by market value included TLN (16.0%)、INDV (13.4%)、ROIV (10.4%). The largest single position, TLN, represented 16.0% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TLN, INDV, ROIV) accounted for 7.8% of total reported equity market value during Q4 2024.
Top New Position Initiated
SPY
市值: $117.2M
Top Position Liquidated / Trimmed
EXEL
前期市值: $35.3M
In Q4 2024, Two Seas Capital LP made 30 total portfolio adjustments, initiating 8 new buys, adding to 14 positions, trimming 4 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.